Novavax trails vaccine developers after setback for COVID-19 shot in India

seekingalpha2021-11-30

Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff. The company shares ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

SL1977
2021-11-30
SL1977
Everyone do you think covid will go away? It will stay with us for many years to come and which means that what is the hurry? Every year we will need to take the shots. Now is moderna next time is novaGiven the extremely long shelf life and 2-8 degree storage of the vaccine. This is why nova will beat out the rivals eventually
- PhoebeReade:
  covid is not likely to disapper. to be honest, it will be our side for life. nova has the most advanced medcial tech.👍🏽
SL1977
2021-11-30
SL1977
What a good time to buy the dip. The vaccine is manufactured in india and not to approve it is a big slap on the india medical communities. Either way it will be approved. The advantage of nova over rivals is obvious. cheaper and better.
- AugustineMac-:
  if nova's vaccine can be proved to use in india market, then the stock price will go much higher.😂
Cumcumber
2021-11-30
Cumcumber
Slow too slow
bwkhoo
2021-11-30
bwkhoo
Traditional technology vs mRNA by AI. What do you think?
Frosty4ever
2021-11-30
Frosty4ever
More of a delay. Hope $nvax learn from this to have a more complete package for approvals.
Zivcheah
2021-11-30
Zivcheah
O
- Cumcumber:
  [Happy]
- ahlimlim:
  like
- Zivcheah:
  O

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1138702575?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-30 07:47","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1138702575","market":"us","top_or_hot":-1,"title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","media":"seekingalpha","content":"<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","article_id":"1138702575","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","pubTimestamp":1638229652,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"在新冠肺炎在印度注射受挫后，诺瓦克落后于疫苗开发商","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":609944579,"gmtCreate":1638234918799,"gmtModify":1638234919357,"author":{"id":"3577882033944507","authorId":"3577882033944507","name":"SL1977","avatar":"https://static.tigerbbs.com/846343ca761b93618fb0332b00e58af9","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Everyone do you think covid will go away? It will stay with us for many years to come and which means that what is the hurry? Every year we will need to take the shots. Now is moderna next time is novaGiven the extremely long shelf life and 2-8 degree storage of the vaccine. This is why nova will beat out the rivals eventually &nbsp;","listText":"Everyone do you think covid will go away? It will stay with us for many years to come and which means that what is the hurry? Every year we will need to take the shots. Now is moderna next time is novaGiven the extremely long shelf life and 2-8 degree storage of the vaccine. This is why nova will beat out the rivals eventually &nbsp;","text":"Everyone do you think covid will go away? It will stay with us for many years to come and which means that what is the hurry? Every year we will need to take the shots. Now is moderna next time is novaGiven the extremely long shelf life and 2-8 degree storage of the vaccine. This is why nova will beat out the rivals eventually","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609944579","repostId":1138702575,"repostType":2,"repost":{"id":"1138702575","pubTimestamp":1638229652,"share":"https://www.laohu8.com/m/news/1138702575?lang=&edition=full","pubTime":"2021-11-30 07:47","market":"us","language":"en","title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","media":"seekingalpha","summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","content":"<p>Novavax&nbsp;has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.</p>\n<p>The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.</p>\n<p>The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,<i>Business Standard</i>, reports.</p>\n<p>While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both&nbsp;Indonesia and the Philippines.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1138702575","content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6780674,"gmtCreate":1638246358478,"gmtModify":1638246358478,"authorId":9000000000000422,"author":{"id":9000000000000422,"authorId":9000000000000422,"name":"PhoebeReade","avatar":"https://static.tigerbbs.com/7245126214eaddb24b9d989ed5703968","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609944579,"type":1,"supId":0,"prevId":0,"content":"covid is not likely to disapper. to be honest, it will be our side for life. nova has the most advanced medcial tech.👍🏽","text":"covid is not likely to disapper. to be honest, it will be our side for life. nova has the most advanced medcial tech.👍🏽","html":"covid is not likely to disapper. to be honest, it will be our side for life. nova has the most advanced medcial tech.👍🏽"}],"langContent":"CN"},{"id":609942919,"gmtCreate":1638234797619,"gmtModify":1638234890122,"author":{"id":"3577882033944507","authorId":"3577882033944507","name":"SL1977","avatar":"https://static.tigerbbs.com/846343ca761b93618fb0332b00e58af9","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"What a good time to buy the dip. The vaccine is manufactured in india and not to approve it&nbsp;is a big&nbsp;slap on the india medical communities. Either way it will be approved. The advantage of nova over rivals is obvious. cheaper and better.&nbsp;","listText":"What a good time to buy the dip. The vaccine is manufactured in india and not to approve it&nbsp;is a big&nbsp;slap on the india medical communities. Either way it will be approved. The advantage of nova over rivals is obvious. cheaper and better.&nbsp;","text":"What a good time to buy the dip. The vaccine is manufactured in india and not to approve it is a big slap on the india medical communities. Either way it will be approved. The advantage of nova over rivals is obvious. cheaper and better.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609942919","repostId":1138702575,"repostType":2,"repost":{"id":"1138702575","pubTimestamp":1638229652,"share":"https://www.laohu8.com/m/news/1138702575?lang=&edition=full","pubTime":"2021-11-30 07:47","market":"us","language":"en","title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","media":"seekingalpha","summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","content":"<p>Novavax&nbsp;has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.</p>\n<p>The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.</p>\n<p>The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,<i>Business Standard</i>, reports.</p>\n<p>While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both&nbsp;Indonesia and the Philippines.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1138702575","content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6780700,"gmtCreate":1638246471712,"gmtModify":1638246471712,"authorId":9000000000000698,"author":{"id":9000000000000698,"authorId":9000000000000698,"name":"AugustineMac-","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609942919,"type":1,"supId":0,"prevId":0,"content":"if nova's vaccine can be proved to use in india market, then the stock price will go much higher.😂","text":"if nova's vaccine can be proved to use in india market, then the stock price will go much higher.😂","html":"if nova's vaccine can be proved to use in india market, then the stock price will go much higher.😂"}],"langContent":"CN"},{"id":609921644,"gmtCreate":1638232965218,"gmtModify":1638233205446,"author":{"id":"3575627435539854","authorId":"3575627435539854","name":"Cumcumber","avatar":"https://static.tigerbbs.com/1e62601ef19050a454d9e0097dbba348","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Slow too slow","listText":"Slow too slow","text":"Slow too slow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609921644","repostId":1138702575,"repostType":2,"repost":{"id":"1138702575","pubTimestamp":1638229652,"share":"https://www.laohu8.com/m/news/1138702575?lang=&edition=full","pubTime":"2021-11-30 07:47","market":"us","language":"en","title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","media":"seekingalpha","summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","content":"<p>Novavax&nbsp;has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.</p>\n<p>The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.</p>\n<p>The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,<i>Business Standard</i>, reports.</p>\n<p>While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both&nbsp;Indonesia and the Philippines.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1138702575","content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609983364,"gmtCreate":1638231394891,"gmtModify":1638231395542,"author":{"id":"3576444918223783","authorId":"3576444918223783","name":"bwkhoo","avatar":"https://static.tigerbbs.com/62d6e46769c7f3e2599cb62434f5f5c3","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Traditional technology vs mRNA by AI. What do you think?&nbsp;","listText":"Traditional technology vs mRNA by AI. What do you think?&nbsp;","text":"Traditional technology vs mRNA by AI. What do you think?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609983364","repostId":1138702575,"repostType":4,"repost":{"id":"1138702575","pubTimestamp":1638229652,"share":"https://www.laohu8.com/m/news/1138702575?lang=&edition=full","pubTime":"2021-11-30 07:47","market":"us","language":"en","title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","media":"seekingalpha","summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","content":"<p>Novavax&nbsp;has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.</p>\n<p>The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.</p>\n<p>The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,<i>Business Standard</i>, reports.</p>\n<p>While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both&nbsp;Indonesia and the Philippines.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1138702575","content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609916325,"gmtCreate":1638230916973,"gmtModify":1638230916973,"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"More of a delay. Hope $nvax learn from this to have a more complete package for approvals.&nbsp;","listText":"More of a delay. Hope $nvax learn from this to have a more complete package for approvals.&nbsp;","text":"More of a delay. Hope $nvax learn from this to have a more complete package for approvals.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609916325","repostId":1138702575,"repostType":2,"repost":{"id":"1138702575","pubTimestamp":1638229652,"share":"https://www.laohu8.com/m/news/1138702575?lang=&edition=full","pubTime":"2021-11-30 07:47","market":"us","language":"en","title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","media":"seekingalpha","summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","content":"<p>Novavax&nbsp;has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.</p>\n<p>The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.</p>\n<p>The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,<i>Business Standard</i>, reports.</p>\n<p>While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both&nbsp;Indonesia and the Philippines.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1138702575","content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":609934962,"gmtCreate":1638230467590,"gmtModify":1638230467757,"author":{"id":"3582538202393061","authorId":"3582538202393061","name":"Zivcheah","avatar":"https://static.tigerbbs.com/d52882be9b594ebb5b5933851792d286","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"O","listText":"O","text":"O","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609934962","repostId":1138702575,"repostType":4,"repost":{"id":"1138702575","pubTimestamp":1638229652,"share":"https://www.laohu8.com/m/news/1138702575?lang=&edition=full","pubTime":"2021-11-30 07:47","market":"us","language":"en","title":"Novavax trails vaccine developers after setback for COVID-19 shot in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1138702575","media":"seekingalpha","summary":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus varian","content":"<p>Novavax&nbsp;has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.</p>\n<p>The company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.</p>\n<p>The Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,<i>Business Standard</i>, reports.</p>\n<p>While FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both&nbsp;Indonesia and the Philippines.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax trails vaccine developers after setback for COVID-19 shot in India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax trails vaccine developers after setback for COVID-19 shot in India\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares ...</p>\n\n<a href=\"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3775053-novavax-trails-vaccine-developers-after-setback-for-covid-19-shot-in-india","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1138702575","content_text":"Novavax has lagged rival developers of COVID-19 vaccines after the newly detected coronavirus variant Omicron sparked a rally across the subsector on Friday amid a market selloff.\nThe company shares underwent a brief trading halt previously after news emerged that regulators in India had sought additional data from the company’s partner there before a potential authorization for its vaccine named Covovax.\nThe Drugs Controller General of India (DCGI) had noted that Covovax also called NVX-CoV2373 had not yet been cleared in its country of origin,Business Standard, reports.\nWhile FDA has yet to authorize the protein subunit vaccine against COVID-19, Novavax(NASDAQ:NVAX)has already won the Emergency Use Authorization (EUA) for the vaccine in both Indonesia and the Philippines.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6777320,"gmtCreate":1638232991984,"gmtModify":1638232992019,"authorId":3575627435539854,"author":{"id":3575627435539854,"authorId":3575627435539854,"name":"Cumcumber","avatar":"https://static.tigerbbs.com/1e62601ef19050a454d9e0097dbba348","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609934962,"type":1,"supId":0,"prevId":0,"content":"[Happy]","text":"[Happy]","html":"[Happy]"},{"id":6776483,"gmtCreate":1638230811881,"gmtModify":1638230811991,"authorId":3585818413942903,"author":{"id":3585818413942903,"authorId":3585818413942903,"name":"ahlimlim","avatar":"https://static.tigerbbs.com/e8e258ebfc948281e97ec47258054c19","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609934962,"type":1,"supId":6776355,"prevId":0,"content":"<u>like</u>","text":"<u>like</u>","html":"<u>like</u>"},{"id":6776355,"gmtCreate":1638230472503,"gmtModify":1638230472582,"authorId":3582538202393061,"author":{"id":3582538202393061,"authorId":3582538202393061,"name":"Zivcheah","avatar":"https://static.tigerbbs.com/d52882be9b594ebb5b5933851792d286","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":609934962,"type":1,"supId":0,"prevId":0,"content":"O","text":"O","html":"O"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":47,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138702575"}